-Barbra A Richardson Researcher Activity Profile

Research Author Detailed Information 

Barbra A Richardson Publication Rate By Year

Barbra A Richardson has published 5 paper(s) in 2006, 13 paper(s) in 2007, 3 paper(s) in 2008, for a total of 21 research publications in total.

Barbra A Ba Richardson Author Information

LAST NAME: richardson

FIRST NAME: Barbra A

INITIALS: ba

AFFILIATION:

Papers

Barbra A Richardson's Publication Record

1. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. Year Published: 2007
Department of Biostatistics, University of Washington, Seattle, WA 98194-2499, USA. barbrar@u.washington.edu
2. Domestic violence and prevention of mother-to-child transmission of HIV-1. Year Published: 2006
Department of Obstetrics/Gynaecology, University of Nairobi, PO Box 3085-00506, Nairobi, Kenya. jkiarie@swiftkenya.com
3. HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers. Year Published: 2006
Departments of Medicine, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA. mcclell@u.washington.edu
4. High levels of cervical HIV-1 RNA during early HIV-1 infection. Year Published: 2006
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
5. Hormonal contraception and the risk of HIV acquisition. Year Published: 2006
Clinical Research Department, Family Health International, Research Triangle Park, North Carolina, USA. cmorrison@fhi.org
6. Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. Year Published: 2006
Departments of Pathobiology, National Primate Research Center, University of Washington, Seattle, Washington 98195, USA.
7. Statistical methods for determining the accuracy of quantitative polymerase chain reaction-based tests. Year Published: 2007
Department of Biostatistics, University of Washington, Seattle, WA 98195, USA. barbrar@u.washington.edu
8. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. Year Published: 2007
Department of Medicine, University of Washington, Seattle, Washington, USA. grahamsm@u.washington.edu
9. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Year Published: 2007
Department of Epidemiology, University of Washington, Seattle, Washington, USA. wisal@u.washington.edu
10. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. Year Published: 2007
Department of Pediatrics, University of Nairobi, Nairobi, Kenya. dalton@africaonline.co.ke
11. Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study. Year Published: 2007
Department of Medicine, University of Washington, Seattle, Washington 98195, USA. grahamsm@u.washington.edu
12. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. Year Published: 2007
Department of Epidemiology, University of California at Los Angeles, 10880 Wilshire Boulevard, Los Angeles, CA 90095, USA. joellebrown@ucla.edu
13. A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression. Year Published: 2007
Department of Medicine, University of Washington, Seattle, Washington 98104, USA. grahamsm@u.washington.edu
14. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. Year Published: 2007
Seattle Biomedical Research Institute, 307 Westlake Ave. N, Seattle, WA 98019, USA.
15. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission. Year Published: 2007
Department of Medicine, University of Washington, Seattle, WA 98104, USA. mhchung@u.washington.edu
16. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. Year Published: 2007
Seattle Biomedical Research Institute, 307 Westlake Ave. N, Seattle, WA 98019, USA.
17. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. Year Published: 2008
Washington National Primate Center, University of Washington, 3000 Western Ave., Seattle, WA 98121, USA.
18. Acute HIV infection among Kenyan infants. Year Published: 2008
Department of Biostatistics, University of Washington, Seattle, Washington, USA.
19. A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression. Year Published: 2007
Department of Medicine, University of Washington, Seattle, Washington 98104, USA. grahamsm@u.washington.edu
20. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission. Year Published: 2007
Department of Medicine, University of Washington, Seattle, WA 98104, USA. mhchung@u.washington.edu
21. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. Year Published: 2008
Washington National Primate Center, University of Washington, 3000 Western Ave., Seattle, WA 98121, USA.